Literature DB >> 21139218

Crystallization and preliminary X-ray crystallographic analysis of a Mycobacterium tuberculosis ferritin homolog, BfrB.

L M McMath1, J E Habel, B Sankaran, M Yu, L-W Hung, C W Goulding.   

Abstract

Mycobacterium tuberculosis (Mtb) is the causative agent of the deadly disease tuberculosis. Iron acquisition, regulation and storage are critical for the survival of this pathogen within a host. Thus, understanding the mechanisms of iron metabolism in Mtb will shed light on its pathogenic nature, as iron is important for infection. Ferritins are a superfamily of protein nanocages that function in both iron detoxification and storage, and Mtb contains both a predicted ferritin and a bacterioferritin. Here, the cloning, expression, purification, crystallization and preliminary X-ray diffraction analysis of the ferritin homolog (Mtb BfrB, Rv3841) is reported. An Mtb BfrB crystal grown at pH 6.5 using the hanging-drop vapor-diffusion technique diffracted to 2.50 Å resolution and belonged to space group C2, with unit-cell parameters a=226.2, b=226.8, c=113.7 Å, β=94.7° and with 24 subunits per asymmetric unit. Furthermore, modeling the crystal structure of a homologous ferritin into a low-resolution small-angle X-ray scattering (SAXS) electron-density envelope is consistent with the presence of 24 subunits in the BfrB protein cage quaternary structure.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21139218      PMCID: PMC2998377          DOI: 10.1107/S1744309110042958

Source DB:  PubMed          Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun        ISSN: 1744-3091


  18 in total

1.  Determination of domain structure of proteins from X-ray solution scattering.

Authors:  D I Svergun; M V Petoukhov; M H Koch
Journal:  Biophys J       Date:  2001-06       Impact factor: 4.033

2.  UCSF Chimera--a visualization system for exploratory research and analysis.

Authors:  Eric F Pettersen; Thomas D Goddard; Conrad C Huang; Gregory S Couch; Daniel M Greenblatt; Elaine C Meng; Thomas E Ferrin
Journal:  J Comput Chem       Date:  2004-10       Impact factor: 3.376

3.  Regulation of the Mycobacterium tuberculosis hypoxic response gene encoding alpha -crystallin.

Authors:  D R Sherman; M Voskuil; D Schnappinger; R Liao; M I Harrell; G K Schoolnik
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-19       Impact factor: 11.205

4.  Solvent content of protein crystals.

Authors:  B W Matthews
Journal:  J Mol Biol       Date:  1968-04-28       Impact factor: 5.469

Review 5.  Ferritins, iron uptake and storage from the bacterioferritin viewpoint.

Authors:  Maria Arménia Carrondo
Journal:  EMBO J       Date:  2003-05-01       Impact factor: 11.598

6.  Mycobacterium tuberculosis gene expression during adaptation to stationary phase and low-oxygen dormancy.

Authors:  M I Voskuil; K C Visconti; G K Schoolnik
Journal:  Tuberculosis (Edinb)       Date:  2004       Impact factor: 3.131

7.  Hypoxic response of Mycobacterium tuberculosis studied by metabolic labeling and proteome analysis of cellular and extracellular proteins.

Authors:  Ida Rosenkrands; Richard A Slayden; Janne Crawford; Claus Aagaard; Clifton E Barry; Peter Andersen
Journal:  J Bacteriol       Date:  2002-07       Impact factor: 3.490

Review 8.  Ferritins: a family of molecules for iron storage, antioxidation and more.

Authors:  Paolo Arosio; Rosaria Ingrassia; Patrizia Cavadini
Journal:  Biochim Biophys Acta       Date:  2008-09-26

9.  Crystal structure of Bfr A from Mycobacterium tuberculosis: incorporation of selenomethionine results in cleavage and demetallation of haem.

Authors:  Vibha Gupta; Rakesh K Gupta; Garima Khare; Dinakar M Salunke; Anil K Tyagi
Journal:  PLoS One       Date:  2009-11-25       Impact factor: 3.240

10.  Phaser crystallographic software.

Authors:  Airlie J McCoy; Ralf W Grosse-Kunstleve; Paul D Adams; Martyn D Winn; Laurent C Storoni; Randy J Read
Journal:  J Appl Crystallogr       Date:  2007-07-13       Impact factor: 3.304

View more
  4 in total

1.  Characterization of a Mycobacterium tuberculosis nanocompartment and its potential cargo proteins.

Authors:  Heidi Contreras; Matthew S Joens; Lisa M McMath; Vincent P Le; Michael V Tullius; Jaqueline M Kimmey; Neda Bionghi; Marcus A Horwitz; James A J Fitzpatrick; Celia W Goulding
Journal:  J Biol Chem       Date:  2014-05-22       Impact factor: 5.157

Review 2.  The tuberculosis drug discovery and development pipeline and emerging drug targets.

Authors:  Khisimuzi Mdluli; Takushi Kaneko; Anna Upton
Journal:  Cold Spring Harb Perspect Med       Date:  2015-01-29       Impact factor: 6.915

3.  Mycobacterium tuberculosis type VII secreted effector EsxH targets host ESCRT to impair trafficking.

Authors:  Alka Mehra; Aleena Zahra; Victor Thompson; Natalie Sirisaengtaksin; Ashley Wells; Maura Porto; Stefan Köster; Kristen Penberthy; Yoshihisha Kubota; Amelie Dricot; Daniel Rogan; Marc Vidal; David E Hill; Andrew J Bean; Jennifer A Philips
Journal:  PLoS Pathog       Date:  2013-10-31       Impact factor: 6.823

4.  A standardized production pipeline for high profile targets from Mycobacterium tuberculosis.

Authors:  Morlin C Milewski; Tobias Broger; Joanna Kirkpatrick; Angela Filomena; Dana Komadina; Nicole Schneiderhan-Marra; Matthias Wilmanns; Annabel H A Parret
Journal:  Proteomics Clin Appl       Date:  2016-08-03       Impact factor: 3.494

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.